Valuation: Sanofi

Market Cap 8.95TCr 10TCr 8.33TCr 7.65TCr 14TCr 9,83100Cr 15TCr 98TCr 39TCr 4,89400Cr 39TCr 38TCr 16,41100Cr P/E 2026 *
12x
P/E 2027 * 10.4x
Enterprise Value 9.92TCr 11TCr 9.24TCr 8.48TCr 16TCr 10,89800Cr 16TCr 1,08900Cr 43TCr 5,42600Cr 43TCr 42TCr 18,19300Cr EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.89x
Free-Float
89.21%
Yield 2026 *
5.69%
Yield 2027 * 6.04%
1 day+2.78%
1 week-2.12%
1 month-1.07%
3 months-6.09%
6 months-5.13%
Current year-9.31%
1 week 36
Extreme 36
39.8
1 month 36
Extreme 36
39.8
Current year 35.6
Extreme 35.6
41.8
1 year 35.6
Extreme 35.6
45
3 years 35.6
Extreme 35.6
54.5
5 years 35.6
Extreme 35.6
54.5
10 years 31.4
Extreme 31.4
54.5
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Tech/Sci/R&D Officer 51 11/09/2023
Director TitleAgeSince
Director/Board Member 60 30/04/2019
Director/Board Member 57 28/04/2020
Director/Board Member 65 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.78%-2.12% - - 10TCr
-0.53%-3.95%+55.23%+152.74% 1,02400Cr
+0.21%-2.68%+55.61%+53.02% 62TCr
-2.51%-3.25%+32.76%+67.76% 44TCr
+0.06%-0.42%+37.53%+30.67% 35TCr
-0.14%-0.24%+34.41%+39.01% 30TCr
-0.69%-0.30%+11.55%+12.93% 26TCr
-7.37%-4.40%-2.54%-43.87% 21TCr
-0.64%+2.43%+30.52%+64.49% 21TCr
-0.82%+0.70%+15.96%+71.01% 16TCr
Average -0.96%-1.20%+30.11%+49.75% 39.71TCr
Weighted average by Cap. -0.88%-1.93%+39.24%+72.95%

Financials

2026 *2027 *
Net sales 4.74TCr 5.45TCr 4.41TCr 4.05TCr 7.65TCr 5,20300Cr 7.76TCr 52TCr 20TCr 2,59000Cr 20TCr 20TCr 8,68500Cr 5.06TCr 5.83TCr 4.71TCr 4.33TCr 8.17TCr 5,56100Cr 8.3TCr 56TCr 22TCr 2,76800Cr 22TCr 21TCr 9,28300Cr
Net income 787.12Cr 905.46Cr 732.63Cr 672.65Cr 1.27TCr 86TCr 1.29TCr 8.64TCr 3.39TCr 43TCr 3.4TCr 3.33TCr 1,44300Cr 944.29Cr 1.09TCr 878.93Cr 806.96Cr 1.52TCr 1,03700Cr 1.55TCr 10TCr 4.07TCr 52TCr 4.08TCr 3.99TCr 1,73100Cr
Net Debt 972.14Cr 1.12TCr 904.86Cr 830.77Cr 1.57TCr 1,06800Cr 1.59TCr 11TCr 4.19TCr 53TCr 4.2TCr 4.11TCr 1,78200Cr 642.05Cr 738.58Cr 597.61Cr 548.68Cr 1.04TCr 71TCr 1.05TCr 7.04TCr 2.76TCr 35TCr 2.77TCr 2.71TCr 1,17700Cr
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change
31/26/31 €37.00 +2.78%
30/26/30 €36.00 -9.55%
29/26/29 €39.80 +0.51%
28/26/28 €39.60 +3.66%
27/26/27 €38.20 +1.06%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
74.47EUR
Average target price
95.05EUR
Spread / Average Target
+27.64%

Quarterly revenue - Rate of surprise